# Adare Pharmaceuticals, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5

> Inspection records and compliance data for Adare Pharmaceuticals, Inc. in Vandalia, Ohio. Access full analysis and detailed observations.

---

## Details

- Name: Adare Pharmaceuticals, Inc.
- FEI Number: 1525864
- City: Vandalia
- State: Ohio
- Country Name: United States
- Address Line 1: 845 Center Dr
- Zip Code: 45377
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [EIR - Adare Pharmaceuticals, Inc. - 2025-02-25](https://www.keypedia.com/records/eir/adare-pharmaceuticals-inc/2a6db835-7b4e-4fa1-9242-45f603486fe4) — source: FDA, date: February 25, 2025
- [483 - Adare Pharmaceuticals, Inc. - 2025-02-25](https://www.keypedia.com/records/483/adare-pharmaceuticals-inc/64722c6e-62b0-426e-baa2-353e3a3f9bed) — source: FDA, date: February 25, 2025
- [FDA Inspection 1261982 - Adare Pharmaceuticals, Inc. - 2025-02-25](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/d31c7419-fc92-4be0-876c-798389f7db7b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 25, 2025
- [EIR - Adare Pharmaceuticals, Inc. - 2019-01-25](https://www.keypedia.com/records/eir/adare-pharmaceuticals-inc/edb3fc64-aacd-4315-81ee-4bd9551461ac) — source: FDA, date: January 25, 2019
- [FDA Inspection 1077858 - Adare Pharmaceuticals, Inc. - 2019-01-25](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/4883a301-a05b-44b7-b8d6-ce59448cb6c8) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2019
- [EIR - Adare Pharmaceuticals, Inc. - 2018-07-11](https://www.keypedia.com/records/eir/adare-pharmaceuticals-inc/c7a03af3-045a-4e4f-b1ff-7ed5e446f720) — source: FDA, date: July 11, 2018
- [FDA Inspection 1063146 - Adare Pharmaceuticals, Inc. - 2018-07-11](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/bbc06fdb-7c36-4fed-bb67-8be26af648a0) — classification: No Action Indicated (NAI), source: FDA, date: July 11, 2018
- [EIR - Adare Pharmaceuticals, Inc. - 2017-05-19](https://www.keypedia.com/records/eir/adare-pharmaceuticals-inc/6ef3867a-34a2-48d9-a556-ef535c36403d) — source: FDA, date: May 19, 2017
- [FDA Inspection 1014959 - Adare Pharmaceuticals, Inc. - 2017-05-19](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/7abcafd9-f6da-49aa-a505-293c978f39d3) — classification: No Action Indicated (NAI), source: FDA, date: May 19, 2017
- [FDA Inspection 904602 - Adare Pharmaceuticals, Inc. - 2014-11-14](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/436cf7ff-505f-4766-8938-270060dcc47c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2014
- [FDA Inspection 809244 - Adare Pharmaceuticals, Inc. - 2012-11-16](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/93d2cffa-8aa3-418f-b772-b89df0156a1c) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2012
- [FDA Inspection 767444 - Adare Pharmaceuticals, Inc. - 2011-12-21](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/516f3bc4-3cd1-4f71-b929-0838bdcf5bfe) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2011
- [FDA Inspection 736349 - Adare Pharmaceuticals, Inc. - 2011-06-17](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/695fd0fd-06f1-41f4-8380-d2fc95a7c8c5) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2011
- [FDA Inspection 629916 - Adare Pharmaceuticals, Inc. - 2009-11-20](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/6fae0498-dbeb-4900-86e2-7f22d2f809da) — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2009

## Related Companies

- [EUGIA Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141)
- [NerPharMa S.r.l.](https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/7d8d0f1a-2012-47a6-99c8-10c2953c39af)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/05d2049f-ed44-40ae-8643-f957dc3c15f9)
- [Quality Chemical Laboratories](https://www.keypedia.com/companies/quality-chemical-laboratories/57f7f773-23e6-4d97-9621-b65592c11e62)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf)
- [Pfizer Ireland Pharmaceuticals Unlimited Company](https://www.keypedia.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/095513de-fb4d-4c57-847c-bef3a3b235f4)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [ALK-Abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/b626f86d-b379-45aa-96d2-0661e9d1c981)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/7b05f5f2-461b-4a95-bfaa-a8c773250712)

## Related Officers

- [recipient](https://www.keypedia.com/people/juan-pablo-gutierrez/071551b6-3ce9-43e9-959d-20fba7c31dd0)
- [company_representative](https://www.keypedia.com/people/andrea-engle/239762c0-b600-44ce-a7e1-63314705c85c)
- [recipient](https://www.keypedia.com/people/douglas-e-wallace/27f160db-2f5d-44c9-ad94-7301d469967a)
- [company_representative](https://www.keypedia.com/people/michael-t-perrin/2d6b3b89-c91c-4f80-b213-fb285d3f64da)
- [investigator](https://www.keypedia.com/people/lauren-n-smith/2f83709d-60f4-4a7f-a839-6bcb8b7fedcf)